International Conference on Clinical Oncology (ICCO - 26)

This track focuses on the latest innovations in the development of anticancer drugs, highlighting novel compounds and therapeutic strategies. Researchers are invited to present findings that explore mechanisms of action, efficacy, and safety profiles of new agents.

This session will delve into the identification and validation of cancer biomarkers that aid in diagnosis, prognosis, and treatment response. Contributions that discuss the clinical implications of biomarker research in various cancer types are particularly encouraged.

This track showcases cutting-edge technologies and methodologies that are transforming cancer research, including genomics, proteomics, and imaging techniques. Presentations should emphasize how these innovations enhance our understanding of cancer biology and treatment.

This session will explore advancements in clinical laboratory practices that improve cancer diagnosis and monitoring. Topics may include novel diagnostic assays, liquid biopsies, and the integration of laboratory findings into clinical decision-making.

This track addresses the epidemiological aspects of cancer, focusing on risk factors, prevention strategies, and public health initiatives. Researchers are encouraged to present studies that highlight effective interventions and population-based approaches to reduce cancer incidence.

This session will cover the latest developments in chemotherapy and radiotherapy, including combination therapies and personalized treatment approaches. Contributions that discuss the challenges and successes in managing treatment-related toxicities are welcome.

This track focuses on the critical aspects of end-of-life care for cancer patients, emphasizing palliative care, symptom management, and psychosocial support. Presentations should address best practices and innovative models of care that enhance the quality of life for patients and families.

This session will explore the unique challenges faced in gynecologic oncology, including early detection, treatment options, and survivorship issues. Researchers are invited to share innovative approaches and research findings that aim to improve outcomes in this field.

This track will focus on the latest advancements in the diagnosis and treatment of genitourinary cancers, including prostate, bladder, and kidney cancers. Contributions that highlight novel therapeutic strategies and clinical trial results are encouraged.

This session will examine the critical role of nursing in oncology care, including integrative approaches that enhance patient outcomes. Presentations should focus on evidence-based practices and the incorporation of complementary therapies in cancer care.

This track addresses the intersection of cancer care and public health policy, focusing on advocacy, access to care, and health disparities. Researchers are invited to present studies that evaluate the impact of policy changes on cancer prevention and treatment outcomes.